News

All news

2016-01-20

Aripiprazole Accord Launch

Accord Healthcare is delighted to announce the launch of Aripiprazole Accord, generic version of Abilify®. The product is available in 5, 10, 15 and 30 mg presentations in packs of 28 tablets.

Aripiprazole Accord is administered orally and has three key indications: schizophrenia, manic episodes in Bipolar I Disorder and recurrence prevention of manic episodes in Bipolar I Disorder.

 

 

All news